Shares of the pharmacy chain plummeted 25% after The Wall Street Journal reported the CEO’s plans and the company lowered its guidance for the full year.
Related Posts
Novo Nordisk’s Wegovy Weight-Loss Drug Gets Approval in China
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, […]
Luxury Brands Increase Prices in Japan Amid Sales Surge, Yen Weakness
Some luxury brands are pushing through price increases in Japan, as tourists snapping up high-end goods turn the country into a bright spot for an […]
Midea Moves Ahead With Hong Kong’s Likely Biggest Listing This Year
Chinese appliance maker Midea Group has started taking orders from investors for an initial public offering to raise up to US$3.46 billion in Hong Kong.